Safety Pharmacology in Pharmaceutical Development and Approval [NOOK Book]

Overview

Safety Pharmacology in Pharmaceutical Development and Approval spells out the whys and hows of safety pharmacology testing. The book covers the background, history, and concerns that have evolved from lackluster safety pharmacology activities in the past. It details regulatory requirements, provides comprehensive information on study designs, and covers both the required battery of studies and the supplemental, follow-up battery.

Until recently, pharmacovigilance has been ...

See more details below
Safety Pharmacology in Pharmaceutical Development and Approval

Available on NOOK devices and apps  
  • NOOK Devices
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK Study
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$169.95
BN.com price

Overview

Safety Pharmacology in Pharmaceutical Development and Approval spells out the whys and hows of safety pharmacology testing. The book covers the background, history, and concerns that have evolved from lackluster safety pharmacology activities in the past. It details regulatory requirements, provides comprehensive information on study designs, and covers both the required battery of studies and the supplemental, follow-up battery.

Until recently, pharmacovigilance has been product - rather than utilization - oriented and often invisible in clinical medicine. It is clear that definitive safety pharmacology standards are needed to combat the increase in adverse reactions seen in the last 20 years. Safety Pharmacology in Pharmaceutical Development and Approval addresses how best to implement ICH safety standards and how to integrate pharmacology safety evaluations into the existing safety evaluations.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Richard H. Alper, PhD (Pfizer Inc.)
Description: This book provides an introduction to the newly developing discipline of safety pharmacology. After an initial overview of the history and regulatory requirements for safety pharmacology, the author provides descriptions of in vivo and in vitro pre-clinical tests used to assess the effects of novel chemical entities on the function of most of the major organ systems.
Purpose: This book was written to answer questions about safety pharmacology and to add clarity to existing requirements. The primary objective is very timely because the discipline is not well recognized even though it is becoming increasingly critical in drug discovery and development. To present a review of the current regulatory environment and the practices used in the discipline is noteworthy. The book falls short in its second goal to add clarity to the existing requirements. As written, it is sometimes difficult for the reader to get a good understanding of the ICH guidelines as compared to the author's interpretation and extension of the guidelines.
Audience: The author does not state the intended audience for this book. The most appropriate audience is likely to be graduate students, academic pharmacologists and toxicologists, and people in related disciplines in academia and industry who are not directly involved in safety pharmacology. This book will provide them with knowledge of the field.
Features: In addition to addressing the regulatory issues, the book covers methodologies used or useful in the functional assessments of organ systems. It might have been clearer had the author included major divisions of the core battery (defined as CNS, cardiovascular and respiratory in the ICH guidelines) and supplemental studies (respiratory, renal, GI and other).
Assessment: The book is nicely written and provides some useful insight into the current state of the field. However, the author intermingles the concepts of safety pharmacology with overall safety assessments in drug development. Safety pharmacology studies are to support first in human studies (FIH) that are most commonly single dose studies in healthy human subjects. Much of the book discusses multidose, pre-clinical protocols using animal models of specific disease states. This might leave the reader with a misconception of what is required of the safety pharmacologist.

2 Stars from Doody
Read More Show Less

Product Details

  • ISBN-13: 9780203499184
  • Publisher: Taylor & Francis, Inc.
  • Publication date: 8/26/2003
  • Sold by: Barnes & Noble
  • Format: eBook
  • Pages: 208
  • File size: 2 MB

Table of Contents

Ch. 1 Safety pharmacology: background, history, issues, and concerns 1
Ch. 2 Regulatory requirements of ICH, U.S. FDA, EMEA, and Japan MHW 17
Ch. 3 Principles of screening and study design 23
Ch. 4 Cardiovascular system 43
Ch. 5 Central nervous system 65
Ch. 6 Respiratory system 81
Ch. 7 Renal function 95
Ch. 8 The gastrointestinal system 109
Ch. 9 Safety pharmacology of the immune system 123
Ch. 10 Integration of evaluations of safety pharmacology endpoints into existing study designs 161
Selected regulatory and toxicological acronyms 177
Safety pharmacology labs 181
Index 185
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)